These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Monocrotaline-Induced Pulmonary Hypertension Involves Downregulation of Antiaging Protein Klotho and eNOS Activity. Varshney R; Ali Q; Wu C; Sun Z Hypertension; 2016 Nov; 68(5):1255-1263. PubMed ID: 27672025 [TBL] [Abstract][Full Text] [Related]
29. miR-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling. Liu T; Zou XZ; Huang N; Ge XY; Yao MZ; Liu H; Zhang Z; Hu CP Life Sci; 2019 Jun; 227():64-73. PubMed ID: 31004656 [TBL] [Abstract][Full Text] [Related]
30. The synergistic therapeutic effect of hepatocyte growth factor and granulocyte colony-stimulating factor on pulmonary hypertension in rats. Guo Y; Su L; Li Y; Guo N; Xie L; Zhang D; Zhang X; Li H; Zhang G; Wang Y; Liu C Heart Vessels; 2014 Jul; 29(4):520-31. PubMed ID: 23933910 [TBL] [Abstract][Full Text] [Related]
31. Nanoparticle endothelial delivery of PGC-1α attenuates hypoxia-induced pulmonary hypertension by attenuating EndoMT-caused vascular wall remodeling. Cai D; Chen SY Redox Biol; 2022 Dec; 58():102524. PubMed ID: 36334380 [TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stem cells attenuate vascular remodeling in monocrotaline-induced pulmonary hypertension rats. Xie J; Hu D; Niu L; Qu S; Wang S; Liu S J Huazhong Univ Sci Technolog Med Sci; 2012 Dec; 32(6):810-817. PubMed ID: 23271278 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic effects of hypoxia-preconditioned bone marrow-derived mesenchymal stromal cells and their extracellular vesicles in experimental pulmonary arterial hypertension. Braga CL; Santos RT; da Silva CM; de Novaes Rocha N; Felix NS; Medeiros M; Melo MM; Silva JD; Teixeira DE; Neves CC; Rocco PRM; Cruz FF; Silva PL Life Sci; 2023 Sep; 329():121988. PubMed ID: 37517581 [TBL] [Abstract][Full Text] [Related]
35. HIMF (Hypoxia-Induced Mitogenic Factor) Signaling Mediates the HMGB1 (High Mobility Group Box 1)-Dependent Endothelial and Smooth Muscle Cell Crosstalk in Pulmonary Hypertension. Lin Q; Fan C; Gomez-Arroyo J; Van Raemdonck K; Meuchel LW; Skinner JT; Everett AD; Fang X; Macdonald AA; Yamaji-Kegan K; Johns RA Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):2505-2519. PubMed ID: 31597444 [TBL] [Abstract][Full Text] [Related]
36. Bone marrow mesenchymal stem cells and condition media diminish inflammatory adhesion molecules of pulmonary endothelial cells in an ovalbumin-induced asthmatic rat model. Rahbarghazi R; Keyhanmanesh R; Aslani MR; Hassanpour M; Ahmadi M Microvasc Res; 2019 Jan; 121():63-70. PubMed ID: 30343002 [TBL] [Abstract][Full Text] [Related]
38. CAR (CARSKNKDC) Peptide Modified ReNcell-Derived Extracellular Vesicles as a Novel Therapeutic Agent for Targeted Pulmonary Hypertension Therapy. Wang J; Hu L; Huang H; Yu Y; Wang J; Yu Y; Li K; Li Y; Tian T; Chen F Hypertension; 2020 Oct; 76(4):1147-1160. PubMed ID: 32829668 [TBL] [Abstract][Full Text] [Related]
39. A ring N(CH Kong S; Yu J; Li HF; Xie YL; Song LF; Wang QQ; Chen YJ; Zhao FR; Zhang WF; Zhu TT Eur J Pharmacol; 2023 Nov; 959():176077. PubMed ID: 37820784 [TBL] [Abstract][Full Text] [Related]
40. [The effect of bone marrow mesenchymal stem cell transplantation on hypoxic pulmonary hypertension in rats]. Tian HJ; Yang JP; Wang XX Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 May; 30(3):233-6. PubMed ID: 25244789 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]